Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases

Area of Science:

• Pulmonary Medicine
• Biomaterials Science
• Mucosal Immunology

Background:

• Respiratory mucus is a key defense gel, crucial for mucociliary clearance.
• In chronic respiratory diseases (CRDs) like asthma, COPD, and cystic fibrosis (CF), mucus overproduction and altered properties impair airway defense.
• This leads to increased susceptibility to microbial infections and airway damage, creating a cycle of obstruction and infection.

Purpose of the Study:

• To review the characteristics of normal and pathological respiratory mucus (sputum) in CRDs.
• To explore the potential of sputum biomarkers for monitoring disease exacerbations and treatment efficacy.

Main Methods:

• Review of literature on mucus composition, structure, and rheology in normal and pathological states.
• Analysis of sputum biomarkers including mucins, inflammatory proteins, peptides, and metabolites.
• Discussion of current and emerging therapeutic strategies affecting mucus properties.

Main Results:

• Pathological mucus in CRDs exhibits altered mucin content, structure (mesh size), rheology, pH, and osmotic pressure.
• Sputum biomarkers show promise for indicating acute exacerbations and response to therapies.
• Evidence suggests treatments can modify sputum properties, but further research is needed.

Conclusions:

• Understanding mucus pathophysiology in CRDs is vital for developing effective treatments.
• Sputum biomarkers offer a potential avenue for personalized medicine in managing CRDs.
• Further investigation is required to validate sputum biomarkers as reliable correlates of disease severity and treatment outcomes.